Efficacy of Combinations of Piperacilline/Tazobactam, Ceftazidime, Amikacin and Bacteriophage against Enterobacteriaceae Sepsis in Neonates: In Vitro Study.

HH Abdul-Jabar, AKH Abd… - Systematic Reviews in …, 2020 - search.ebscohost.com
… to evaluate the antibacterial activity of bacteriophages alone … sepsis and to obtain desired
antibacterial combinations for the … In this study, the combinations of piperacillin /tazobactam or …

Impact of surfactants and other body fluids on in vitro activity of a novel β-lactamase inhibitor enmetazobactam in combination with cefepime against clinical isolates of …

A Nussbaumer-Pröll, S Eberl, A Belley… - The Journal of …, 2023 - nature.com
… determined for FPE and piperacillin-tazobactam (TZP) with … tazobactam [7], for new
combinations, it is important to determine if target site components can affect their antibacterial activity

Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with …

M Attwood, P Griffin, AR Noel, M Albur… - … of Antimicrobial …, 2023 - academic.oup.com
… vitro pharmacokinetic model of Pseudomonal infection that a free T > MIC ceftolozane
target in the presence of tazobactam for … Pharmacokinetic characteristics of piperacillin-tazobactam

Clearance of PiperacillinTazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation

L Sharrock, MJ Ankravs, AM Deane… - Therapeutic drug …, 2023 - journals.lww.com
… However, data on its effect on the pharmacokinetics of antibiotics … the clearance of
piperacillintazobactam and vancomycin in … the pharmacokinetics of vancomycin and piperacillin–…

Brain exposure to piperacillin in acute hemorrhagic stroke patients assessed by cerebral microdialysis and population pharmacokinetics

S Ullah, R Beer, U Fuhr, M Taubert, M Zeitlinger… - Neurocritical Care, 2020 - Springer
… It is generally believed that piperacillin and tazobactam exhibit similar pharmacokinetics [34]
and tazobactam does not affect the pharmacokinetic behavior of piperacillin [35]. However, …

[PDF][PDF] COMPARISON OF CONTINUOUS VS INTERMITTENT ADMINISTRATION OF PIPERACILLIN-TAZOBACTAM IN HIGH RISK INFECTIONS: A META ANALYSIS

JP Sarmiento-Reotan, PP Salandanan, ED Monsayac - giresearch.ph
… to improve patient outcomes and lower antibiotic-related costs. (… the effects of continuous
infusion of Pipperacillin/Tazobactampharmacokinetics and pharmacodynamics of Piperacillin

Design of a novel colorimetric method based on AuNPs for tazobactam and piperacillin detection

Z Erdogan, H Balcı - Journal of Research in Pharmacy, 2023 - avesis.bilecik.edu.tr
… for the determination of tazobactam and piperacillin based on plasmonic nanoparticles (…
Piperacillin/tazobactam: a review of its antibacterial activity, pharmacokinetic properties and …

Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the …

A Henderson, DL Paterson, MD Chatfield… - Clinical Infectious …, 2021 - academic.oup.com
Introduction This study aims to assess the association of piperacillin/tazobactam and
meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with …

Association between piperacillin/tazobactam MIC and survival among hospitalized patients with Enterobacterales infections: retrospective cohort analysis of electronic …

JR Strich, A Lawandi, S Warner… - JAC-Antimicrobial …, 2023 - academic.oup.com
Introduction A recent randomized trial has suggested an increased risk of mortality for
ceftriaxone-non-susceptible Enterobacterales infections treated with piperacillin/tazobactam

Drug Utilization Evaluation and Impact of Pharmacist Interventions on Optimization of Piperacillin/Tazobactam Use: A Retrospective Analysis and Prospective Audit

S Arain, F Khalawi, SA Parakkal, HS AlHamad… - Antibiotics, 2023 - mdpi.com
Piperacillin/tazobactam is a combination of β-lactam/β-lactamase inhibitors. It has a broad
spectrum of antibacterial activity … to alterations in the pharmacokinetic properties of several …